- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cannabis use not linked with increased risk for periodontitis
No association was found between the use of cannabis and the aetiology of periodontal disease according to a recent study published in the Journal of Clinical Periodontology
Periodontitis is a microbially associated inflammatory disease of the tooth-supporting tissue that affects approximately 50% of the adult population, with 10% suffering from severe periodontitis. It is a major cause of tooth loss. Subgingival bacterial dysbiosis, diabetes mellitus, and tobacco smoking are well-recognized risk factors for periodontitis. Cannabis is the most widely smoked substance after tobacco, and its prevalence is increasing as more legal markets emerge. There is strong evidence from prospective observational studies, Mendelian randomization (MR) studies, and laboratory-based studies that tobacco smoking increases the risk of periodontitis. Cannabis smoke shares many of the chemical constituents of tobacco, except for cannabinoids and nicotine. The well-established effect of tobacco smoke on the periodontium and the oral mucosa and the similarities in the toxicological profiles of tobacco and cannabis smoke suggest that cannabis may also be a candidate in the aetiology of periodontal disease.
This study aimed to leverage human genetic data to investigate whether cannabis use causally affects periodontitis.
Data were obtained from summary statistics of genome-wide association studies of lifetime cannabis use (N = 184,765), cannabis use disorder (17,068 cases; 357,219 controls), and periodontitis (17,353 cases; 28,210 controls). We performed two-sample Mendelian randomization (MR) analysis using 6 genetic variants as instrumental variables for lifetime cannabis use and 11 variants as instruments for cannabis use disorder to estimate associations with periodontitis.
Results
- There was no evidence for an association between genetic liability for lifetime cannabis use or cannabis use disorder with periodontitis.
- The estimates from the primary analyses were supported in multivariable MR analysis, which considered potential pleiotropic pathways and in weak instrument analyses.
This study provides little evidence to support the detrimental effect of genetic liability for cannabis use on periodontal health.
Reference:
Baumeister, S.-E., Alayash, Z., Baurecht, H., Reckelkamm, S. L., Kocher, T., Holtfreter, B., Ehmke, B., & Nolde, M. (2022). Cannabis use and the risk of periodontitis: A two-sample Mendelian randomization study. Journal of Clinical Periodontology, 49( 7), 654– 661. https://doi.org/10.1111/jcpe.13632
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751